Teduglutide Peptide CAS 197922-42-2

Teduglutide Peptide is a glucagon like peptide-2 (GLP-2) analogue with the following main functions:
Promoting intestinal remodeling: It has the function of promoting intestinal remodeling. It stimulates the proliferation and growth of intestinal mucosal cells, helps increase surface area, and thus enhances the absorption capacity of the intestine. This effective intestinal remodeling helps improve the patient's nutrient absorption and reduce symptoms such as diarrhea and bloating.
Improving the absorption capacity of nutrients: Patients with short bowel syndrome often suffer from malnutrition and electrolyte imbalance due to weakened absorption function. It can significantly enhance the absorption capacity of nutrients, including key nutrients such as protein, fat, and carbohydrates, by increasing the intestinal absorption area and improving absorption function.
Reducing dependence on intravenous nutrition: For patients with short bowel syndrome, long-term dependence on intravenous nutrition is a burden and inconvenience, while also increasing the risk of infection and other complications. It can significantly reduce patients' dependence on intravenous nutrition, allowing them to sustain their lives more through oral intake of nutrients.
Relieve malnutrition and electrolyte imbalance: Its therapeutic effect is also manifested in relieving patients' malnutrition and electrolyte imbalance. Due to the decreased absorption capacity of patients with short bowel syndrome, they may experience weight loss, malnutrition, and electrolyte imbalance. Its treatment helps to improve these issues, enhance the patient's nutritional status, and maintain normal electrolyte balance.